Biocides

The Biocidal Products Directive 98/8/EC (BPD) seeks to establish a high level of protection for humans and the environment, and to eliminate barriers to trade by harmonizing the processes involved in placing biocidal products on the European market. But it will also dramatically transform the biocidal industry, since it will have far-reaching effects on those who produce, distribute and use active substances.

The BPD describes biocides as chemical preparations containing one or more active substances that are intended to control harmful organisms by either chemical or biological means.
The classification of biocides is broken down into 23 Product Types (i.e. application categories), with several comprising different subgroups.

Under the BPD, the system of approval requires two regulatory submissions before a biocidal product can be marketed: the first on the active substances, and the second on the formulated biocidal products.Each requires a dossier per product type that contains information on its biocidal efficacy, toxicological and ecotoxicological properties, etc.
Read more information on the submitted product types page.

Progress thus far

The dossiers submitted in 2007 have passed the evaluation period and are currently subject to commenting from the member states.
See the Draft competent authority report on circa.europa.eu

The dossiers submitted in 2008 are currently undergoing evaluation by the Rapporteur Member State.

Following steps

At the next step we wait for the comments from the MS and the response from the RMS to these comments. After this the draft competent authority report will be referred to the Technical Meeting to discuss any further issues of contention.

On the agency website you can follow the annex I entries by clicking on these links:

Biocidal Products Regulation

The new Biocidal Products Regulation is expected to come into force on the 1st of January 2013. Given the timelines of the active substance registration, it seems likely that the products based on our active substances will be registered under this new regime. We are currently following developments at the EU level to ascertain how this will affect our registrations.